Претраживање
Приказ резултата 1-10 од 12
Suppressing prostate cancer by targeting NGAL
(International Journal of Molecular Medicine, 2014)
Inhibition of GSK-3 beta activity can result in drug and hormonal resistance and alter sensitivity to targeted therapy in breast cancer
(International Journal of Molecular Medicine, 2014)
Targeting signaling pathways in prostate cancer
(International Journal of Molecular Medicine, 2012)
NO-hybridized protease inhibitors as a new class of anticancer compounds. Saquinavir-NO as prototypical example?
(International Journal of Molecular Medicine, 2012)
Role of NGAL (Lcn2) in prostate cancer invasion
(International Journal of Molecular Medicine, 2012)
Macrophage migration inhibitory factor as potential therapeutic target for prevention and treatment of autoimmune diabetogenesis. Lessons from animal models
(International Journal of Molecular Medicine, 2009)
Different action of nitric oxide-modified forms of saquinavir and izoxazole dentate VGX-1027 in colon cancer cells
(International Journal of Molecular Medicine, 2010)
Novel approaches to target the prostate cancer stem cell - eliminating the root of the cancer
(International Journal of Molecular Medicine, 2011)
Anti-melanoma potential of nitric oxide-modified form of HIV inhibitor- saquinavir; cell specific mode of drug action
(International Journal of Molecular Medicine, 2010)
Generation of new anti-cancer compounds from Nitric Oxide (NO)-hybridization of protease inhibitors. Saquinavir-NO as prototypic example?
(International Journal of Molecular Medicine, 2010)